CStone Pharmaceuticals
OTC: CSPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jianxin Yang
- Employees
- 135
- Headquarters
- Shanghai, China
- IPO year
- 2020
- Market cap
- $951.2M
- Website
- https://www.cstonepharma.com
Loading CSPHF…
Loading profile data…Frequently asked questions about CSPHF
What does CStone Pharmaceuticals (CSPHF) do?
CStone Pharmaceuticals is a biopharmaceutical firm dedicated to discovering, developing, and marketing innovative immuno-oncology and precision medicine therapies. Their primary objective is to fulfill critical medical requirements for cancer patients, both within China and across global markets. The company currently provides several key therap...
Where does CSPHF trade?
CStone Pharmaceuticals (CSPHF) trades on the Other OTC.
What sector is CSPHF in?
CStone Pharmaceuticals (CSPHF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CStone Pharmaceuticals?
Jianxin Yang is the chief executive officer of CStone Pharmaceuticals (CSPHF).
Where is CStone Pharmaceuticals headquartered?
CStone Pharmaceuticals is headquartered in China.
Does CSPHF pay a dividend?
CStone Pharmaceuticals (CSPHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CSPHF go public?
CStone Pharmaceuticals (CSPHF) completed its initial public offering in 2020.